3 new drugs/indications were approved by FDA Oncology for Breast Cancer and 2 for Gyn Onc in 2022. Here is a summary! - #TDXd x 2 - #Olaparib - #Pembrolizumab - #Mirvetuximab #bcsm #gynsm OncoAlert #breastcancer #MedTwitter #OncEd #MedEd #ovariancancer

Undergraduate Paid Summer Internship for students interested in genetic counseling! This is a great opportunity with the University of Pennsylvania MSGC Program! #GCchat #geneticcounseling instagram.com/p/CnQK-7GuSBQ/…

JUST IN: The paper we all quote every year is out: "Cancer statistics, 2023" @CAonline Despite #COVID19, death continued to decline from 2019 to 2020 (-1.5%). This is a 33% overall reduction since 1991 & estimated 3.8 million deaths averted! acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… OncoAlert

We’re on-site at ASCO #GI23 presenting 6 abstracts throughout the weekend, featuring research dedicated to improving therapy options for patients with #GI cancers. Stop by booth 52 or learn more here: tempus.co/3WoFQ2O

Check out the 1st episode of our Prostate Cancer #Genetics Podcast talking about genetic counseling for #prostatecancer w/ certified genetic counselor Tamara Braid & Veda Giri. Link to the full episode: anchor.fm/pcagenetics/ep… ZERO Prostate Cancer Prostate Cancer Foundation AnCan Foundation Amer. Urol. Assn.

We all can make a difference during #NationalCancerPreventionMonth and beyond by spreading the message of importance of cancer screening, healthy lifestyle, and knowing family history of cancer-one individual, family, and community at a time! Yale Cancer Center

Hello everyone! We are excited to announce another virtual hours for Thursday, Feb 16th at 7pm PST. 💖🧬 This is a great opportunity to chat and decompress with fellow prospective students! ➡️Register here: linktr.ee/GCPSN⬅️ #GeneChat

If you have had >=10 adenomatous polyps &/or sessile serrated polyps removed in a single colonoscopy, you need to: 1. Repeat your colonoscopy in 1 year & 2. See your friendly genetic counselor Find one at findageneticcounselor.com #ColorectalCancerAwarenessMonth

It's not too late to register for this week’s webinar exploring the potential utility of complementary #solidtumor & #liquidbiopsy testing in informing treatment decisions, & patient management strategies in the post CDK4/6 inhibitor therapy setting. tempus.co/3mS3IQs

Excited to announce a collaboration w/ Former Account of Eli Lilly and Company to offer our molecular profiling offerings at no cost – designed to expand access to #genomictesting for eligible patients who have advanced or metastatic MTC or advanced or metastatic non-MTC. Learn more: bit.ly/3nPKYle

I will be attending the Society of Gynecologic Nurse Oncologists (SGNO) 38th Annual Symposium on April 27th to the 29th. Let me know If you are interested in meeting and hearing more about what we are doing at Tempus Labubu! 🧬

Amie Blanco discussing adding a Genetic Testing Station to pancreatic cancer clinic. ⬆️ testing from 19% to 71%. Tried to offer post-test GC to all patients but quickly changed to only seeing positive patients with letters to negatives. Disparities persisted. #COHGenomics23

Beautiful day to get outside! 🥾⛰#lakegeorgehiking #lakegeorge

The perfect Mother’s Day card doesn’t exi—

Join us for our #ASCO23 Industry Expert Theater Session in Theater 2! We will dive into Tempus’ AI-enabled precision medicine platform, which rapidly delivers insights that are transforming patient care and research. Learn more: tempus.co/3VRiOTw

We’re excited to be on-site at #ASCO23 exhibiting 20 abstracts, including research that demonstrates how the tumor-normal match feature of our xT assay may detect germline alterations and inform patient care across different cancer types. Learn more: tempus.co/3oDWMHS

Take 🏡 points: 🔹Germline genetic testing with a “Test first, counsel later” approach is feasible with high patient and provider satisfaction in cancer patients. 🔹Next steps: implementation in a broader, multi-site center.

A must read! Germline genetic testing after a cancer diagnosis: analysis of >1.3M individuals shows very low rates of testing (~7%) & marked inequities. jamanetwork.com/journals/jama/… Allison Kurian

Early Detection of Pancreatic Cancer Saved My Life - The ASCO Post. Makes the case for screening for pancreatic cancer in BRCA2 carriers #PRECEDE #pancreatic cancer #early detection#BRCA ascopost.com/issues/june-10…

Allison Kurian's recent paper revealed only 1% of patients with #prostatecancer undergo germline genetic testing. This #ProstateCancerAwarenessMonth, let's highlight the importance of genetic testing! To learn more: hubs.li/Q020VS2v0 #GeneChat #PrecisionMedicine